Digoxin for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and trial sequential analysis of randomised clinical trials

A review of rate control in atrial fibrillation, and the rationale and protocol for the RATE-AF trial

(2017) Dipak Kotecha et al.   BMJ Open

The Epidemiology of Atrial Fibrillation and Stroke

(2016) Francesca Pistoia et al.   CARDIOLOGY CLINICS

Systematic review and meta-analysis of mortality and digoxin use in atrial fibrillation

(2016) Waqas Qureshi et al.   Cardiology Journal

Evidence-based clinical practice: Overview of threats to the validity of evidence and how to minimise them

(2016) Silvio Garattini et al.   European Journal of Internal Medicine

Atrial flutter: Clinical risk factors and adverse outcomes in the Framingham Heart Study

(2016) Faisal Rahman et al.   HEART RHYTHM

2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia

(2016) Richard L. Page et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

False-positive findings in Cochrane meta-analyses with and without application of trial sequential analysis: an empirical review

(2016) Georgina Imberger et al.   BMJ Open

Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis

(2016) Ayodele Odutayo et al.   BMJ-British Medical Journal

Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis

(2016) Ayodele Odutayo et al.   BMJ-British Medical Journal

Meta-Analysis of Digoxin Use and Risk of Mortality in Patients With Atrial Fibrillation

(2015) Ai-Jun Ouyang et al.   AMERICAN JOURNAL OF CARDIOLOGY

Systematic Reviews of Anesthesiologic Interventions Reported as Statistically Significant

(2015) Georgina Imberger et al.   ANESTHESIA AND ANALGESIA

Heart Disease and Stroke Statistics—2016 Update

(2015) Dariush Mozaffarian et al.   CIRCULATION

Digoxin-associated mortality: a systematic review and meta-analysis of the literature

(2015) Mate Vamos et al.   EUROPEAN HEART JOURNAL

Digoxin Is Associated With Increased All-cause Mortality in Patients With Atrial Fibrillation Regardless of Concomitant Heart Failure

(2015) Zhi-Quan Wang et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Arrhythmia-Induced Cardiomyopathies

(2015) Rakesh Gopinathannair et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Rate- and Rhythm-Control Therapies in Patients With Atrial Fibrillation

(2014) Sana M. Al-Khatib et al.   ANNALS OF INTERNAL MEDICINE

Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods

(2014) Janus Christian Jakobsen et al.   BMC Medical Research Methodology

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2013) David Moher   ANNALS OF INTERNAL MEDICINE

Influence of Reported Study Design Characteristics on Intervention Effect Estimates From Randomized, Controlled Trials

(2013) Jelena Savović et al.   ANNALS OF INTERNAL MEDICINE

SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials

(2013) An-Wen Chan et al.   ANNALS OF INTERNAL MEDICINE

Urgent Management of Rapid Heart Rate in Patients With Atrial Fibrillation/Flutter and Left Ventricular Dysfunction

(2013) Ryozo Nagai et al.   CIRCULATION JOURNAL

2012 focused update of the ESC Guidelines for the management of atrial fibrillation

(2012) et al.   EUROPACE

Heart rate: surrogate or target in the management of heart failure?

(2012) M. Bohm et al.   HEART

Evidence at a glance: error matrix approach for overviewing available evidence

(2010) Frederik Keus et al.   BMC Medical Research Methodology

GRADE guidelines: A new series of articles in the Journal of Clinical Epidemiology

(2010) Gordon H. Guyatt et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Lenient versus Strict Rate Control in Patients with Atrial Fibrillation

(2010) Isabelle C. Van Gelder et al.   NEW ENGLAND JOURNAL OF MEDICINE

CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomised Trials

(2010) Kenneth F. Schulz et al.   PLOS MEDICINE

Estimating required information size by quantifying diversity in random-effects model meta-analyses

(2009) Jørn Wetterslev et al.   BMC Medical Research Methodology

Intravenous diltiazem is superior to intravenous amiodarone or digoxin for achieving ventricular rate control in patients with acute uncomplicated atrial fibrillation*

(2009) Chung-Wah Siu et al.   CRITICAL CARE MEDICINE

Therapeutic Considerations in Applying Rate Control Therapy for Atrial Fibrillation

(2009) D George Wyse   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Comparison of Beta Blocker and Digoxin Alone and in Combination for Management of Patients With Atrial Fibrillation and Heart Failure

(2008) Laurent Fauchier et al.   AMERICAN JOURNAL OF CARDIOLOGY

Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?

(2008) Kristian Thorlund et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Apparently conclusive meta-analyses may be inconclusive—Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses

(2008) Jesper Brok et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses

(2008) Jesper Brok et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study

(2008) Lesley Wood et al.   BMJ-British Medical Journal

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

(2008) Gordon H Guyatt et al.   BMJ-British Medical Journal

Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis

(2007) Jørn Wetterslev et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY